Cite
HARVARD Citation
Schulz, E. et al. (2012). Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms. Journal of medical genetics. 49 (7), pp. 422-428. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schulz, E. et al. (2012). Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms. Journal of medical genetics. 49 (7), pp. 422-428. [Online].